UM

Browse/Search Results:  1-3 of 3 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo Journal article
Cancer Letters, 2014,Volume: 354,Issue: 2,Page: 398-406
Authors:  Han L.;  Wang W.;  Lu J.;  Kong F.;  Ma G.;  Zhu Y.;  Zhao D.;  Zhu J.;  Shuai W.;  Zhou Q.;  Chen P.;  Ye L.;  Tao J.;  Ahmad S.;  Li F.;  Sun J.
Favorite  |  View/Download:8/0  |  Submit date:2019/01/15
AAV  BTLA  HSP70 vaccine  Immunotherapy  Metastatic melanoma  
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy Journal article
Protein Engineering, Design and Selection, 2014,Volume: 27,Issue: 6,Page: 179-190
Authors:  Kwok H.F.;  Botkjaer K.A.;  Tape C.J.;  Huang Y.;  McCafferty J.;  Murphy G.
Favorite  |  View/Download:6/0  |  Submit date:2018/12/19
Anti-tace Antibody  Exosite  Immunoreactivity  Phage-display Randomization Libraries  Sub-nanomolar Affinity  
Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy Journal article
Biomaterials, 2014,Volume: 35,Issue: 38,Page: 10046
Authors:  Zhan X.;  Jia L.;  Niu Y.;  Qi H.;  Chen X.;  Zhang Q.;  Zhang J.;  Wang Y.;  Dong L.;  Wang C.
Favorite  |  View/Download:7/0  |  Submit date:2018/10/30
Bisphosphonate  Bletilla Striata Polysaccharide  Cancer Immunotherapy  Glucomannan  Macrophage Mannose Receptor  Tumour-associated Macrophages